Myeloid Programs

Myeloid cells, such as immunosuppressive macrophages, play a significant role in shaping the immunosuppressive tumor microenvironment and are critical for tumor development. Consequently, blocking myeloid cells may offer a complementary strategy to checkpoint inhibitors and provide new treatment solutions for non-responsive or relapsing patients as well as expand the patient population responsive to immunotherapies.